A unique blood test for early detection of pancreatic cancer is undergoing clinical trials. Meanwhile, the Czech company Lipidica is not resting on its laurels and is simultaneously working on the development of software using artificial intelligence. Thanks to this, it could fully automate the method for detecting pancreatic cancer in the future. The development was financially supported by the Ministry of Industry and Trade in the TWIST program.
Lipidica represents the Czech Republic at EXPO 2025
In Japan, it will present a unique test for early detection of pancreatic cancer
The ongoing EXPO 2025 will have a significant Czech footprint. The Czech National Pavilion in Osaka, Japan will also present the spin-off company Lipidica, based on the research of scientists from the University of Pardubice on Friday, 25 July. Its aim is to put into practice non-invasive testing for early detection of pancreatic cancer.
Japanese Patent
Method for Detecting Pancreatic Cancer
Our method for the early detection of pancreatic cancer is patented not only in the European Union, but also in the United States, Singapore and Japan.
Our laboratory successfully certified according to the international standard EN ISO 13485:2016
We are pleased to announce that our laboratory has successfully passed the certification process and has met all the requirements of the international standard EN ISO 13485:2016.
We have received an accreditation certificate in accordance with ČSN EN ISO 15189 ed. 3:2023
Based on meeting the requirements for quality and competence of a medical laboratory, the Lipidica laboratory received a Certificate of Accreditation according to ČSN EN ISO 15189 ed. 3:2023.
Lipidica has a US patent!
Method for detecting pancreatic cancer
We are happy to share with you great news – our innovative method for early detection of pancreatic cancer was successfully patented in the United States of America in March! This significant milestone is the result of an almost five-year process, during which it underwent a thorough assessment by the US patent offices.
Publication of an article in the Czech Society of Clinical Biochemistry journal
Clinical Biochemistry and Metabolism 3/2024
The Lipidica research team published an article in the Czech Society of Clinical Biochemistry journal Clinical Biochemistry and Metabolism.
World Pancreatic Cancer Day
21. 11. 2024
Today we commemorate World Pancreatic Cancer Day, one of the most insidious types of cancer with a low chance of cure if not detected early. This disease often occurs without significant symptoms until advanced stages, which significantly reduces the possibilities of treatment and worsens the prognosis of patients.
We attended the IMSC 2024 conference
The International Mass Spectrometry Conference (IMSC)
The International Mass Spectrometry Conference (IMSC) is a world-renowned conference where news and modern trends in the field of mass spectrometry are presented. This conference is held regularly every 2 years and the 25th edition took place in the second half of August in Melbourne, Australia.
